InsidersTradesSigma
Track the 威尔药业 share price and the full insider trade history of the company, a listed issuer based in China. Shares trade on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 威尔药业 has logged 3 reports. Market capitalisation: €3.1bn. The latest transaction was disclosed on 24 March 2023 (Sale). Among the most active insiders: 王福秋. The full history is free.
3
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€819,071
3 ops.
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 10,872 of 29,063 companies
57.9
score / 100
Value61
Quality55
FCF yld5.9%
Earn yld4.8%
EV/EBITDA11.8x
ROE8.4%
Gross mgn28%
Net mgn11%
Debt/EBITDA1.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 24 March 2023
Acerca de 威尔药业
威尔药业 es una empresa que opera en el sector de la salud y farmacéutico, cotizada en la Bolsa de Shanghái. Se enfoca en el desarrollo y comercialización de productos farmacéuticos innovadores.